ALLR Allarity Therapeutics, Inc. - Common stock
$1,60
Prix · Mai 22, 2026
Données fondamentales au Mai 15, 2026
Fourchette 52 semaines
$1–$2
52% of range
Note des analystes
BUY
7 analysts
Objectif de cours
$10
+509% upside
P/E (TTM)
-0.0
ROE
-102.1%
Marge nette
-3509.7%
ALLR Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$1.60
Capitalisation Boursière
$17M
P/E (TTM)
-0.0
BPA (TTM)
$-10.26
Revenus (TTM)
$320.0K
Rendement div.
—
ROE
-102.1%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $2
ALLR Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$320.0K
2024-12-31
→
2025-12-31
BPA
$-10.26
2021-12-31
→
2023-12-31
Flux de trésorerie libre
$-15M
2022-12-31
→
2025-12-31
Marges
-3509.7%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ALLR
Médiane des pairs
P/E (TTM)
-0.0
—
P/S (TTM)
54.3
14.0
P/B
1.8
2.0
Price / FCF (Cours / FCF)
-1.2
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ALLR
Médiane des pairs
Operating Margin (Marge d'exploitation)
-3939.1%
—
Net Profit Margin (Marge nette)
-3509.7%
-3396.1%
ROA
-54.9%
-68.9%
ROE
-102.1%
-110.3%
ROIC
-128.3%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ALLR
Médiane des pairs
Current Ratio (Ratio de liquidité)
2.1
1.4
Quick Ratio (Ratio de liquidité réduite)
1.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ALLR
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ALLR
Médiane des pairs
ALLR Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
7 analystes
- Achat fort 2 28,6%
- Achat 4 57,1%
- Conserver 1 14,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
1 analystes · 2026-05-26
Bas
$9.75
Haut
$9.75
Objectif médian
$9.75
+509,4%
Objectif moyen
$9.75
+509,4%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
1.1%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.17 | $-0.22 | 0.05% |
| 31 décembre 2025 | $-0.21 | $-0.22 | 0.01% |
| 30 septembre 2025 | $-0.19 | $-0.23 | 0.04% |
| 30 juin 2025 | $-0.15 | $-0.21 | 0.06% |
| 30 septembre 2024 | $-7.71 | $-8.69 | 0.98% |
| 30 juin 2024 | $-3.30 | $-8.78 | 5.5% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
| SHPH | $4M | -0.3 | 0.00% | — | -400.1% | — |
| DYAI | — | -4.1 | -11.6% | — | — | — |
| AIXC | $12M | -0.3 | — | — | -110.8% | — |
| CLRB | — | -0.4 | — | — | — | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| JSPR | — | -0.5 | — | — | — | — |
| VTGN | — | -1.5 | -54.3% | -10579.8% | -67.9% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 13
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue | $320.0K | $0 | |
| R&D Expense | $7M | $6M | |
| SG&A Expense | $6M | $11M | |
| Operating Expenses | $13M | $27M | |
| Operating Income | $-13M | $-27M | |
| Interest Income | $801.0K | $533.0K | |
| Other Non-op | $1M | $2M | |
| Pretax Income | $-11M | $-25M | |
| Income Tax | $0 | $-381.0K | |
| Net Income | $-11M | $-25M | |
| EPS (Basic) | $-0.78 | $-15.65 | |
| Shares (Basic) | 14,378,942 | 1,606,989 | |
| EBITDA | $-13M | $-27M |
Bilan 21
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $20M | |
| Prepaid Expense | $2M | $507.0K | |
| Other Current Assets | $265.0K | $115.0K | |
| Current Assets | $18M | $22M | |
| PP&E (Net) | $330.0K | $309.0K | |
| Intangibles | · | $0 | |
| Total Assets | $18M | $23M | |
| Accounts Payable | $4M | $4M | |
| Accrued Liabilities | $3M | $5M | |
| Short-term Debt | $0 | · | |
| Current Liabilities | $8M | $11M | |
| Deferred Tax | · | $0 | |
| Total Liabilities | $8M | $11M | |
| Common Stock | $3.0K | $1.0K | |
| Paid-in Capital | $144M | $131M | |
| Retained Earnings | $-130M | $-119M | |
| Treasury Stock | $3M | $0 | |
| AOCI | $-1M | $-354.0K | |
| Stockholders' Equity | $10M | $12M | |
| Liabilities + Equity | $18M | $23M | |
| Shares Outstanding | 16,080,980 | 7,302,797 |
Flux de trésorerie 13
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| D&A | · | $9.0K | |
| Stock-based Comp | $482.0K | $71.0K | |
| Deferred Tax | $0 | $-381.0K | |
| Other Non-cash | · | $7M | |
| Operating Cash Flow | $-15M | $-17M | |
| CapEx | $8.0K | $298.0K | |
| Investing Cash Flow | $-8.0K | $-298.0K | |
| Stock Issued | $11M | $37M | |
| Stock Repurchased | $3M | $0 | |
| Net Stock Activity | $8M | $37M | |
| Financing Cash Flow | $11M | $37M | |
| Taxes Paid | · | $0 | |
| Free Cash Flow | $-15M | $-18M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -3939.1% | · | |
| Net Margin | -3509.7% | · | |
| Pretax Margin | -3509.7% | · | |
| EBITDA Margin | -3939.1% | · | |
| ROA | -54.9% | -142.1% | |
| ROE | -102.1% | -197.9% | |
| ROIC | -128.3% | -227.1% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.1 | 2.1 | |
| Quick Ratio | 1.7 | 1.8 |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $320.0K | $0 | |
| Net Income TTM | $-11M | $-25M | |
| Market Cap | $17M | $9M | |
| P/E | -0.0 | -0.0 | |
| P/S | 54.3 | · | |
| P/B | 1.8 | 0.7 | |
| P / Tangible Book | 1.8 | 0.7 | |
| P / Cash Flow | -1.2 | -0.5 | |
| P / FCF | -1.2 | -0.5 | |
| Earnings Yield | -50908.3% | -46992.3% |
Compte de résultat 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $25.0K | · | · | · | $0 | |
| R&D Expense | $1M | $2M | $1M | $2M | $1M | |
| SG&A Expense | $1M | $2M | $1M | $2M | $2M | |
| Operating Expenses | $3M | $3M | $3M | $4M | $3M | |
| Operating Income | $-3M | $-3M | $-3M | $-4M | $-3M | |
| Interest Income | $163.0K | $155.0K | $187.0K | $237.0K | $222.0K | |
| Other Non-op | $-62.0K | $-455.0K | $-288.0K | $2M | $304.0K | |
| Pretax Income | · | $-3M | $-3M | $-2M | $-3M | |
| Income Tax | · | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-3M | $-3M | $-2M | $-3M | |
| EPS (Basic) | $-0.17 | $-0.19 | $-0.19 | $-0.15 | $-0.25 | |
| Shares (Basic) | 15,968,591 | -27,051,101 | 14,739,800 | 15,543,321 | 11,146,922 | |
| EBITDA | $-3M | · | $-3M | $-4M | $-3M |
Bilan 20
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $15M | $17M | $18M | $25M | |
| Prepaid Expense | $4M | $2M | $2M | $1M | $493.0K | |
| Other Current Assets | $108.0K | $265.0K | $113.0K | $116.0K | $110.0K | |
| Current Assets | $35M | $18M | $20M | $21M | $29M | |
| PP&E (Net) | $420.0K | $330.0K | $330.0K | $322.0K | $308.0K | |
| Total Assets | $35M | $18M | $21M | $21M | $30M | |
| Accounts Payable | $4M | $4M | $5M | $5M | $4M | |
| Accrued Liabilities | $2M | $3M | $3M | $3M | $5M | |
| Short-term Debt | $20M | · | · | · | · | |
| Current Liabilities | $28M | $8M | $9M | $9M | $11M | |
| Total Liabilities | $28M | $8M | $9M | $9M | $11M | |
| Total Debt | $20M | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $144M | $144M | $144M | $141M | $141M | |
| Retained Earnings | $-133M | $-130M | $-127M | $-124M | $-122M | |
| Treasury Stock | $3M | $3M | $3M | $3M | · | |
| AOCI | $-1M | $-1M | $-2M | $-2M | $-630.0K | |
| Stockholders' Equity | $7M | $10M | $12M | $12M | $19M | |
| Liabilities + Equity | $35M | $18M | $21M | $21M | $30M | |
| Shares Outstanding | 15,818,980 | 16,080,980 | 16,111,461 | 14,619,636 | 17,021,970 |
Flux de trésorerie 11
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | · | · | · | $12.0K | $11.0K | |
| Stock-based Comp | $160.0K | $47.0K | $132.0K | $164.0K | $139.0K | |
| Other Non-cash | · | · | · | · | $-104.0K | |
| Operating Cash Flow | $-4M | $-3M | $-3M | $-5M | $-3M | |
| CapEx | $64.0K | · | · | · | $0 | |
| Investing Cash Flow | $-64.0K | · | · | · | $0 | |
| Stock Issued | $0 | $0 | $0 | $0 | $11M | |
| Stock Repurchased | $262.0K | $484.0K | $141.0K | $3M | $0 | |
| Net Stock Activity | $-262.0K | · | · | · | $11M | |
| Financing Cash Flow | $20M | $-240.0K | $2M | $-3M | $11M | |
| Free Cash Flow | $-5M | · | · | · | · |
Rentabilité 6
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Margin | -10752.0% | · | · | · | · | |
| Net Margin | -11000.0% | · | · | · | · | |
| EBITDA Margin | -10752.0% | · | · | · | · | |
| ROA | -8.5% | · | -13.6% | -8.9% | -13.1% | |
| ROE | -21.5% | · | -22.5% | -14.5% | -44.8% | |
| ROIC | · | · | -21.0% | -34.0% | -16.3% |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | · | 2.3 | 2.3 | 2.7 | |
| Quick Ratio | 0.7 | · | 1.9 | 2.0 | 2.3 | |
| Debt / Equity | 2.9 | · | · | · | · |
Efficacité 1
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · |
Valorisation (TTM) 11
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | · | $-19M | $-18M | $-20M | |
| Market Cap | $17M | · | $25M | $15M | $16M | |
| Enterprise Value | $18M | · | · | · | · | |
| P/E | -0.0 | · | -0.0 | -0.0 | -0.0 | |
| P/B | 2.5 | · | 2.1 | 1.2 | 0.9 | |
| P / Tangible Book | 2.5 | · | 2.1 | 1.2 | 0.9 | |
| P / Cash Flow | -3.8 | · | · | · | -5.9 | |
| P / FCF | -3.8 | · | · | · | · | |
| EV / EBITDA | -6.5 | · | · | · | · | |
| EV / FCF | -3.8 | · | · | · | · | |
| Earnings Yield | -50441.3% | · | -34798.1% | -54436.6% | -58677.7% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $320.0K | $0 | — | — | — |
| Marge d'exploitation % | -3939.1% | — | — | — | 1971.5% |
| Résultat net | $-11M | $-25M | $-12M | $-16M | $-27M |
| BPA dilué | — | — | $-10.26 | $-3093.42 | $-4.19 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 2.1 | 2.1 | — | 0.4 | 1.0 |
| Ratio de liquidité réduite | 1.7 | 1.8 | — | 0.2 | 0.9 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-15M | $-18M | — | $-17M | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.